Myungjun Kim, Kyungwon Park and Doojin Hong acquired 6.95% stake in MiraeING.Co.,Ltd. from Young-Ho Kim for KRW 7.6 billion.
June 07, 2016
Share
Myungjun Kim, Kyungwon Park and Doojin Hong acquired 6.95% stake in MiraeING.Co.,Ltd. (KOSE:A007120) from Young-Ho Kim for KRW 7.6 billion on June 3, 2016. Myungjun Kim and Kyungwon Park acquired 1.5 million shares each from Young-Ho Kim at KRW 1900 per share. Doojin Hong acquired 1 million shares from Young-Ho Kim at KRW 1900 per share. Pursuant to the transaction, Young-Ho Kim does not hold any stake in MiraeING.Co.,Ltd.
Myungjun Kim, Kyungwon Park and Doojin Hong completed the acquisition of 6.95% stake in MiraeING.Co.,Ltd. (KOSE:A007120) from Young-Ho Kim on June 3, 2016.
MiraeING.Co.,Ltd., formerly Theall Medi Bio. Co.,Ltd., is a Korea-based company mainly engaged in solution business and video business. The Company operates in three main segments: solution segment, which provides project consulting, construction and maintenance services and related products for banks under the brand name XiT, eNisis and others; video segment, which provides digital video recorders (DVRs) and closed circuit television (CCTV) systems for security areas, and defense segment, which provides self-propelled artilleries and components. It also engages in the leasing of non-residential buildings.
MIRAEING.CO.,LTD. 
